Concerns of Parents/Caregivers of Children With Food Allergy During COVID-19
The effect of coronavirus disease 2019 (COVID-19) on patients with food allergy and their parents and caregivers is substantial.
The effect of coronavirus disease 2019 (COVID-19) on patients with food allergy and their parents and caregivers is substantial.
Researchers conducted a retrospective analysis of patients with COPD who were hospitalized and mechanically ventilated.
In the first 30 days following an exacerbation of chronic obstructive pulmonary disease, there is an increased risk of cardiovascular adverse events.
Expired or previously used and sterilized N95 respirators can be used when new N95 respirators are unavailable during the COVID-19 pandemic.
Extrapyramidal symptoms that developed in patients with schizophrenia after initiation of treatment with atypical antipsychotic agents were associated with increased healthcare resources and costs.
The Theraflu Home FluTest, a novel rapid influenza diagnostic test, demonstrated good sensitivity and specificity for both influenza A and B viruses.
In patients who were hospitalized with severe coronavirus disease, treatment with lopinavir-ritonavir did not provide a substantial benefit beyond standard care.
The leadership of American Thoracic Society recently released a statement, as well as 2 fact sheets, in response to the COVID-19 outbreak.
The COPD Foundation released practical recommendations for patients living with COPD who may have concerns about COVID-19.
Sputum cell count, as measured by a simplified method, was able to differentiate between asthma, COPD, and asthma-COPD overlap.